<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03811236</url>
  </required_header>
  <id_info>
    <org_study_id>1911/2017</org_study_id>
    <nct_id>NCT03811236</nct_id>
  </id_info>
  <brief_title>Cold-induced Brown Fat Activation and Hepatic Steatosis</brief_title>
  <official_title>Cold-induced Brown Fat Activation and Hepatic Steatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the recent years, research on brown adipose tissue (BAT) revealed that larger amounts as
      well as higher activity thereof are associated with a favourable metabolic phenotype.
      Longitudinal studies which applied recurrent cooling sessions demonstrated a high plasticity
      of BAT which significantly increased in size and activity during these studies. These changes
      were accompanied by improvements in body fat mass as well as insulin sensitivity.
      Non-alcoholic fatty liver disease (NAFLD) is estimated to advance to the primary cause of
      liver cirrhosis and hepatocellular carcinoma in the following years. Besides predisposing
      genetic and possibly nutritional factors, the insulin resistance syndrome and obesity are the
      main factors contributing to this excessive hepatic lipid accumulation.

      The aim of this study is to investigate whether BAT recruitment via cold-acclimation results
      in decreased hepatic lipid content in overweight/obese patients with NAFLD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic lipid content (%)</measure>
    <time_frame>Six weeks</time_frame>
    <description>Magnetic resonance imaging-proton density fat fraction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brown adipose tissue volume (ml) / activity (SUVmean)</measure>
    <time_frame>Six weeks</time_frame>
    <description>18-fluorodeoxyglucose positron emission tomography/ magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basal metabolic rate (kcal/day/kg fat-free body mass)</measure>
    <time_frame>Six weeks</time_frame>
    <description>Indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cold-induced non-shivering thermogenesis (%)</measure>
    <time_frame>Six weeks</time_frame>
    <description>Indirect calorimetry: percentage increase in basal metabolic rate before and after cold exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat mass (kg)</measure>
    <time_frame>Six weeks</time_frame>
    <description>Air displacement plethysmography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>Six weeks</time_frame>
    <description>&quot;Matsuda Index&quot; for 2 hour standard oral glucose tolerance test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Non-Alcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>Cold exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Room temperature</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold exposure</intervention_name>
    <description>Two hours of mild cold exposure using a water-perfused vest</description>
    <arm_group_label>Cold exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  body mass index 28 - 40 kg/m^2

          -  hepatic lipid content &gt; 10 %

        Exclusion Criteria:

          -  endocrine disease, except treated hypo-/hyperthyroidism and hypertriglyceridemia (&lt;500
             mg/dl) and untreated type II diabetes mellitus (fasting glucose &lt; 140 mg/dl)

          -  use of beta-blockers, alpha-blockers and rilmenidine

          -  chronic kidney disease

          -  inflammatory bowel disease

          -  active malignant disease

          -  autoimmune disease

          -  chronic alcohol abuse or alcohol consumption greater than 30g/d for men or 20 g/d for
             women

          -  transferrin saturation &gt; 40%

          -  serum alpha-1 antitrypsin &lt; 90 mg/dl

          -  serum ceruloplasmin &lt; 20 mg/dl

          -  positive serology for autoimmune hepatitis

          -  positive hepatitis serology

          -  liver cirrhosis

          -  portal hypertension

          -  pregnancy

          -  contraindications for magnetic resonance imaging
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Kiefer, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florian Kiefer, MD, PhD</last_name>
    <phone>+43140400</phone>
    <phone_ext>43120</phone_ext>
    <email>florian.kiefer@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Kiefer, MD, PhD</last_name>
      <phone>+43140400</phone>
      <phone_ext>43120</phone_ext>
      <email>florian.kiefer@meduniwien.ac.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 18, 2019</study_first_submitted>
  <study_first_submitted_qc>January 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2019</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Florian Kiefer</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

